RT Journal Article
SR Electronic
T1 Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004495
DO 10.1136/jitc-2022-004495
VO 10
IS 6
A1 Papadatos-Pastos, Dionysis
A1 Yuan, Wei
A1 Pal, Abhijit
A1 Crespo, Mateus
A1 Ferreira, Ana
A1 Gurel, Bora
A1 Prout, Toby
A1 Ameratunga, Malaka
A1 Chénard-Poirier, Maxime
A1 Curcean, Andra
A1 Bertan, Claudia
A1 Baker, Chloe
A1 Miranda, Susana
A1 Masrour, Nahal
A1 Chen, Wentin
A1 Pereira, Rita
A1 Figueiredo, Ines
A1 Morilla, Ricardo
A1 Jenkins, Ben
A1 Zachariou, Anna
A1 Riisnaes, Ruth
A1 Parmar, Mona
A1 Turner, Alison
A1 Carreira, Suzanne
A1 Yap, Christina
A1 Brown, Robert
A1 Tunariu, Nina
A1 Banerji, Udai
A1 Lopez, Juanita
A1 de Bono, Johann
A1 Minchom, Anna
YR 2022
UL http://jitc.bmj.com/content/10/6/e004495.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.